Comparative evaluation of Apamarga Kshar and Palasha Kshar Lepa in Raktarsha (IInd and IIIrd degree Haemorrhoids)
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 34
- 试验地点
- 1
- 主要终点
- Outcome will be measured by parameters:
研究概览
简要总结
Selected drug: Apamarga Kshar and Palasha Kshar
Form of medicine: Kshar will be applied in the form of Kshar Lepa as explained in the classical text
Composition of medicine: Apamarga Panchang, Palasha Patra
Preparation of medicine: Apamarga Kshar and Palasha Kshar will be prepared according to the classical views.
Dose of medicine: Kshar paste will be applied on each pile mass according to its size with protection of normal mucosa
Route of administration: Local application procedure:
Method of Kshar Administration: The procedure of selected patients will be done in lithotomy position. Firstly anal canal and perianal area will be cleaned with antiseptic lotion. Proctoscopic examination will be done for confirmation of number and position of Arsha. These Arsha wil be made to protude in the slit proctoscope. After that Kshar will be applied with spatula on Arsha and then we will wait for 100 matrakal (2 minutes). Then the applied Kshar will be washed with nimbu swara. After the process, Arsha will become reddish brown ( Pakwajambuphal Sadrishya) in colour. It shows Samyak Lakshana of Kshar Lepa. Same procedure will be repeated on other mass of Arsha, if present.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 16.00 Year(s) 至 70.00 Year(s)(—)
- 性别
- All
入选标准
- •• Patients of age group between 16-70 years.
- •• Patients who are suffering from second and third degree of haemorrhoids will be considered for this study.
排除标准
- •• I and IV degrees of piles.
- •• Arsha associated with carcinoma rectum, thrombosed & strangulated piles, rectalprolapse, fistula in ano and fissure in ano.
- •• Hepatitis-B, HIV and HCV positive cases.
- •• Patients having uncontrolled systemic disease such as hypertension, diabetesmellitus etc.,malignancy of any organ and pregnant women will also be excluded.
结局指标
主要结局
Outcome will be measured by parameters:
时间窗: Outcome will be evaluated every 7th day for 3 weeks
1.Bleeding per anus
时间窗: Outcome will be evaluated every 7th day for 3 weeks
2.Pain in anal region
时间窗: Outcome will be evaluated every 7th day for 3 weeks
3.Number of pile mass
时间窗: Outcome will be evaluated every 7th day for 3 weeks
4.Size of pile mass
时间窗: Outcome will be evaluated every 7th day for 3 weeks
次要结局
- 1.Mucous discharge(2.constipation)
研究者
Dr Vishal Verma
Rishikul Campus, Uttarakhand Ayurved University, Haridwar
